NCT00101439View on ClinicalTrials.gov

A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

November 10, 2005

Primary Completion Date

October 24, 2006

Study Completion Date

November 8, 2006

Conditions
Hypercholesterolemia
Interventions
DRUG

ezetimibe

DRUG

Comparator: placebo

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00101439 - A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED) | Biotech Hunter | Biotech Hunter